Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,099,000 | 3,670,000 | 3,563,000 | 3,343,000 | 2,437,000 |
| Marketable Securities | 17,559,000 | 26,586,000 | 24,145,000 | 32,779,000 | 31,009,000 |
| Receivables | 9,535,000 | 8,951,000 | 8,920,000 | 8,401,000 | 9,955,000 |
| Inventories | 7,678,000 | 5,796,000 | 5,786,000 | 5,663,000 | 6,355,000 |
| Income taxes - deferred | 4,883,000 | 4,263,000 | 4,214,000 | 2,566,000 | 4,687,000 |
| Other current assets | 2,247,000 | 2,449,000 | 2,815,000 | 2,843,000 | 2,544,000 |
| TOTAL | $45,001,000 | $51,715,000 | $49,443,000 | $55,595,000 | $56,987,000 |
| Non-Current Assets | |||||
| PPE Net | 13,695,000 | 11,432,000 | 11,527,000 | 11,762,000 | 12,032,000 |
| Investments And Advances | 16,233,000 | 17,650,000 | 18,289,000 | 17,518,000 | 18,451,000 |
| Intangibles | 90,514,000 | 74,995,000 | 76,188,000 | 77,235,000 | 79,098,000 |
| Other Non-Current Assets | 5,423,000 | 5,085,000 | 5,193,000 | 5,457,000 | 4,794,000 |
| TOTAL | $125,865,000 | $109,162,000 | $111,197,000 | $111,972,000 | $114,375,000 |
| Total Assets | $170,867,000 | $160,878,000 | $160,640,000 | $167,566,000 | $171,362,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,818,000 | 8,394,000 | 6,555,000 | 5,141,000 | 5,389,000 |
| Accounts payable and accrued liabilities | 3,294,000 | 2,930,000 | 2,724,000 | 3,210,000 | 2,973,000 |
| Accrued Expenses | 2,155,000 | 1,646,000 | 1,679,000 | 1,841,000 | 1,841,000 |
| Other current liabilities | 9,672,000 | 8,390,000 | 8,320,000 | 9,153,000 | 8,824,000 |
| TOTAL | $27,845,000 | $24,143,000 | $20,222,000 | $21,587,000 | $19,920,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,079,000 | 26,729,000 | 29,370,000 | 31,541,000 | 31,666,000 |
| Other Non-Current Liabilities | 18,155,000 | 18,158,000 | 18,982,000 | 19,492,000 | 15,145,000 |
| TOTAL | $75,897,000 | $69,555,000 | $72,832,000 | $74,358,000 | $73,137,000 |
| Total Liabilities | $103,743,000 | $93,698,000 | $93,053,000 | $95,944,000 | $93,057,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,173,002 | 6,167,348 | 6,157,670 | 6,128,856 | 6,300,657 |
| Common Shares | 459,000 | 458,000 | 458,000 | 455,000 | 455,000 |
| Retained earnings | 74,019,000 | 73,620,000 | 74,471,000 | 72,176,000 | 74,292,000 |
| Other shareholders' equity | -8,858,000 | -8,207,000 | -8,246,000 | -6,965,000 | -3,120,000 |
| TOTAL | $67,124,000 | $67,180,000 | $67,587,000 | $71,622,000 | $78,305,000 |
| Total Liabilities And Equity | $170,867,000 | $160,878,000 | $160,640,000 | $167,566,000 | $171,362,000 |